Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
Boehringer Ingelheim
McKesson
Harvard Business School
McKinsey

Last Updated: December 8, 2019

DrugPatentWatch Database Preview

ACTAVIS LABS UT INC Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for ACTAVIS LABS UT INC, and what generic and branded alternatives to ACTAVIS LABS UT INC drugs are available?

ACTAVIS LABS UT INC has eighteen approved drugs.

There are three tentative approvals on ACTAVIS LABS UT INC drugs.

Summary for ACTAVIS LABS UT INC
US Patents:0
Tradenames:18
Ingredients:13
NDAs:18

Drugs and US Patents for ACTAVIS LABS UT INC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Ut Inc NORINYL 1+50 28-DAY mestranol; norethindrone TABLET;ORAL-28 016659-001 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial
Actavis Labs Ut Inc FENTANYL-100 fentanyl FILM, EXTENDED RELEASE;TRANSDERMAL 076709-004 Aug 20, 2007 DISCN No No   Start Trial   Start Trial
Actavis Labs Ut Inc PIMECROLIMUS pimecrolimus CREAM;TOPICAL 209345-001 Dec 27, 2018 AB RX No No   Start Trial   Start Trial
Actavis Labs Ut Inc TESTOSTERONE testosterone GEL;TRANSDERMAL 076737-001 Jan 27, 2006 AB1 RX No No   Start Trial   Start Trial
Actavis Labs Ut Inc CLONIDINE clonidine FILM, EXTENDED RELEASE;TRANSDERMAL 090873-001 May 6, 2014 AB RX No No   Start Trial   Start Trial
Actavis Labs Ut Inc NORINYL mestranol; norethindrone TABLET;ORAL-20 013625-004 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Actavis Labs Ut Inc FLUOCINOLONE ACETONIDE fluocinolone acetonide SOLUTION;TOPICAL 208386-001 Oct 21, 2016 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Express Scripts
Medtronic
Harvard Business School
AstraZeneca
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.